During the intake process, you will select a preferred GLP-1 option
NR administration benefits blood pressure, carotid-femoral pulse waves, maximal muscle strength, and fatigue in healthy subjects [180]
If the FDA finalizes its April 30, 2026 proposal to exclude semaglutide and tirzepatide from the 503B Bulks List, large-scale 503B compounding of those medications would no longer be legally permissible
BPC-157 has been discussed by the FDA in the context of bulk drug substances that may present significant safety risks, and TB-500 is generally promoted in research-peptide settings rather than as an FDA-approved therapeutic product
It is not indicated for type 1 diabetes or diabetic ketoacidosis
Ask your doctor which medication has the best formulary placement on your specific plan